These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1835723)

  • 1. Allergic cross-reaction of teicoplanin and vancomycin.
    Grek V; Andrien F; Collignon J; Fillet G
    J Antimicrob Chemother; 1991 Sep; 28(3):476-7. PubMed ID: 1835723
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic cross-reactivity to teicoplanin and vancomycin.
    Davenport A
    Nephron; 1993; 63(4):482. PubMed ID: 8459893
    [No Abstract]   [Full Text] [Related]  

  • 3. IgE-mediated reaction to vancomycin and teicoplanin after treatment with vancomycin.
    Knudsen JD; Pedersen M
    Scand J Infect Dis; 1992; 24(3):395-6. PubMed ID: 1380722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergic cross-reactivity of teicoplanin and vancomycin.
    McElrath MJ; Goldberg D; Neu HC
    Lancet; 1986 Jan; 1(8471):47. PubMed ID: 2867290
    [No Abstract]   [Full Text] [Related]  

  • 5. Reaction to teicoplanin with tolerance to vancomycin.
    Macías E; Moreno E; Dávila I; Laffond E; Ruíz A; Batista JC; Lorente F
    J Investig Allergol Clin Immunol; 2008; 18(1):71-2. PubMed ID: 18361107
    [No Abstract]   [Full Text] [Related]  

  • 6. High risk of cross-reactivity between vancomycin and sequential teicoplanin therapy.
    Hsiao SH; Chou CH; Lin WL; Lee EJ; Liao LH; Chang HJ; Yeh PY; Lin CY; Wu TJ
    J Clin Pharm Ther; 2012 Jun; 37(3):296-300. PubMed ID: 22017186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teicoplanin for patients allergic to vancomycin.
    Schlemmer B; Falkman H; Boudjadja A; Jacob L; Le Gall JR
    N Engl J Med; 1988 Apr; 318(17):1127-8. PubMed ID: 2965303
    [No Abstract]   [Full Text] [Related]  

  • 8. Teicoplanin in patients who are allergic to vancomycin.
    Wood G; Whitby M
    Med J Aust; 1989 Jun; 150(11):668. PubMed ID: 2524639
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of hypersensitivity syndrome to both vancomycin and teicoplanin.
    Kwon HS; Chang YS; Jeong YY; Lee SM; Song WJ; Kim HB; Kim YK; Cho SH; Kim YY; Min KU
    J Korean Med Sci; 2006 Dec; 21(6):1108-10. PubMed ID: 17179696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teicoplanin-induced hypersensitivity syndrome with a preceding vancomycin-induced neutropenia: a case report and literature review.
    Hsiao SH; Chen HH; Chou CH; Lin WL; Liu Yeh PY; Wu TJ
    J Clin Pharm Ther; 2010 Dec; 35(6):729-32. PubMed ID: 21054466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the safety profile of teicoplanin.
    Davey PG; Williams AH
    J Antimicrob Chemother; 1991 Apr; 27 Suppl B():69-73. PubMed ID: 1829079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A four-year-old child with teicoplanin allergy but no evidence of cross-reaction with vancomycin.
    de Vries E; van Weel-Sipman MH; Vossen JM
    Pediatr Infect Dis J; 1994 Feb; 13(2):167. PubMed ID: 8190551
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence of teicoplanin adverse drug reactions among patients with vancomycin-associated adverse drug reactions and its risk factors.
    Kim BK; Kim JH; Sohn KH; Kim JY; Chang YS; Kim SH
    Korean J Intern Med; 2020 May; 35(3):714-722. PubMed ID: 31722513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enzyme immunoassay for the determination of the glycopeptide antibiotic eremomycin].
    Burkin MA; Burkin AA
    Prikl Biokhim Mikrobiol; 2009; 45(2):232-6. PubMed ID: 19382713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations for cross-reactivity between vancomycin and other glycopeptides.
    Nakkam N; Trubiano J; Gibson A; Phillips EJ
    J Allergy Clin Immunol Pract; 2021 Aug; 9(8):3233. PubMed ID: 34366100
    [No Abstract]   [Full Text] [Related]  

  • 16. Glycopeptide-induced neutropenia: cross-reactivity between vancomycin and teicoplanin.
    Hsiao SH; Chang CM; Tsai JC; Lin CY; Liao LH; Lin WL; Wu TJ
    Ann Pharmacother; 2007 May; 41(5):891-4. PubMed ID: 17426073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Tarasi A; Cassone M; Monaco M; Tarasi D; Pompeo ME; Venditti M
    J Chemother; 2003 Jun; 15(3):239-43. PubMed ID: 12868549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glycopeptide-induced cutaneous adverse reaction: results of an immunoallergic investigation in eight patients].
    Perrin-Lamarre A; Petitpain N; Trechot P; Cuny JF; Schmutz JL; Barbaud A
    Ann Dermatol Venereol; 2010 Feb; 137(2):101-5. PubMed ID: 20171430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red-man syndrome after vancomycin: potential cross-reactivity with teicoplanin.
    Khurana C; de Belder MA
    Postgrad Med J; 1999 Jan; 75(879):41-3. PubMed ID: 10396588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
    Sidi V; Roilides E; Bibashi E; Gompakis N; Tsakiri A; Koliouskas D
    J Chemother; 2000 Aug; 12(4):326-31. PubMed ID: 10949982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.